✦ LIBER ✦

Combined haemoperfusion, haemofiltration and haemodialysis for systemic detoxification in locoregional 5-fluorouracil therapy

✍ Scribed by Frieder Keller; Uwe Gallkowski; Wolfgang Roth; Joachim Boese-Landgraf

Publisher: Springer
Year: 1991
Tongue: English
Weight: 316 KB
Volume: 29
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00687329

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy of intraarterial 5-f

Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion

✍ Shuntaro Obi; Haruhiko Yoshida; Risa Toune; Tadao Unuma; Miho Kanda; Shinpei Sat 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

Combination therapy of intra-arterial 5-

Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma

✍ Kazuhiro Kasai; Akira Ushio; Yukiho Kasai; Kei Sawara; Yasuhiro Miyamoto; Kanta 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 379 KB

Combination therapy with mitomycin C, 5-

Combination therapy with mitomycin C, 5-fluorouracil, and cytosine arabinoside for nonresectable malignant tumor in man

✍ Takayuki Yamaguchi; Masanori Nakamura 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB

The effectiveness of MFC (mitomycin C, 5-fluorouracil and cytosine arabinoside) therapy for nonresectable cancers and cancers recurring after surgery was investigated in 60 patients with solid cancers aged 26 to 69 years. Treatment was effective in 28 patients (47%) including seven (12%) who showed

Combined intraarterial 5-fluorouracil an

Combined intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

✍ Masato Sakon; Hiroaki Nagano; Keizo Dono; Shoji Nakamori; Koji Umeshita; Akira Y 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB

Preclinical rationale for combined use o

Preclinical rationale for combined use of endocrine therapy and 5-fluorouracil but neither doxorubicin nor paclitaxel in the treatment of endocrine-responsive breast cancer

✍ Junichi Kurebayashi; Mamoru Nukatsuka; Hiroshi Sonoo; Junji Uchida; Mamoru Kiniw 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 589 KB

Therapeutic efficacy of multimodal combi

Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma

✍ Jeong Won Jang; Young Min Park; Si Hyun Bae; Jong Young Choi; Seung Kew Yoon; U 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 199 KB